American Century Companies’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84M Buy
4,610,989
+358,627
+8% +$6.53M 0.05% 433
2025
Q1
$84.4M Buy
4,252,362
+478,800
+13% +$9.5M 0.05% 388
2024
Q4
$64.7M Sell
3,773,562
-436,091
-10% -$7.48M 0.04% 518
2024
Q3
$84.2M Sell
4,209,653
-1,844,664
-30% -$36.9M 0.05% 392
2024
Q2
$67.7M Sell
6,054,317
-1,074,194
-15% -$12M 0.04% 447
2024
Q1
$47M Buy
7,128,511
+315,820
+5% +$2.08M 0.03% 582
2023
Q4
$30.8M Buy
6,812,691
+1,920,568
+39% +$8.68M 0.02% 702
2023
Q3
$17.5M Buy
4,892,123
+840,761
+21% +$3.01M 0.01% 850
2023
Q2
$14.9M Buy
4,051,362
+2,936,092
+263% +$10.8M 0.01% 888
2023
Q1
$3.68M Buy
+1,115,270
New +$3.68M ﹤0.01% 1368